Search
for

    Glossary Odds Ratio

    compares the odds of an event occurring between two groups

    The Odds Ratio (OR) is a statistical measure used to determine the strength of association between two events, often used in medical research. For example, in a study examining the link between a specific treatment and hair regrowth in individuals with alopecia, an OR greater than 1 suggests that the treatment is associated with higher odds of hair regrowth, while an OR less than 1 suggests lower odds.

    Sort by

    Research 30 of 1000+

    1. Why Odds Ratios Can Be Tricky Statistics The Journal of Clinical Psychiatry · 2018 · 3 citations
    2. Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta‐analysis 2018 · 48 citations
    3. A Meta-Analysis on the Relationship Between Hair Dye and the Incidence of Non-Hodgkin’s Lymphoma Medical principles and practice · 2018 · 6 citations
    4. Longer TA repeat but not V89L polymorphisms in the SRD5A2 gene may confer acne risk in the Chinese population Postępy Dermatologii i Alergologii · 2018 · 3 citations
    5. Hyperpigmentation post laser hair removal in patients taking Vitamin D supplements Journal of Dermatology and Dermatologic Surgery · 2021 · 1 citations
    6. Exploring the association between alcohol consumption and androgenic alopecia: a systematic review and meta-analysis Alcohol and Alcoholism · 2024
    7. Alopecia androgenética masculina de inicio precoz asociada a cáncer de próstata 2017
    8. Contraception hormonale et cancer du sein : Une question de contexte Journal of Obstetrics and Gynaecology Canada · 2007
    9. Assessing dutasteride-associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System Journal of the European Academy of Dermatology and Venereology · 2017 · 7 citations
    10. Diagnostic accuracy measures for vertical and transverse scalp biopsies in cicatricial and non-cicatricial alopecias Dermatologica Sinica · 2017 · 5 citations
    11. Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase Journal of The American Academy of Dermatology · 2022 · 4 citations
    12. Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System Pharmaceuticals · 2026
    13. Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System Preprints.org · 2026
    14. Cognitive dysfunction following finasteride use: a disproportionality analysis of the global pharmacovigilance database Expert Opinion on Drug Safety · 2023
    15. Supplementary Material for: Monotherapy for Alopecia Areata: A Systematic Review and Network Meta-Analysis Figshare · 2019
    16. Sun behaviors and quality of life after first cutaneous melanoma diagnosis Journal of The American Academy of Dermatology · 2018
    17. Sun protection policies and behaviors among U.S. child care centers Journal of The American Academy of Dermatology · 2018
    18. Sunscreen: Cosmetic or medical therapy? Journal of The American Academy of Dermatology · 2018
    19. En pacientes jóvenes, el uso de finasteride podría asociarse con mayor riesgo de ansiedad, depresión y eventos adversos relacionados con el suicidio Evidencia · 2021
    20. Race and Alopecia Areata amongst US Women Journal of Investigative Dermatology Symposium Proceedings · 2017 · 37 citations
    21. Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study Journal of The American Academy of Dermatology · 2023
    22. Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System. PubMed · 2020
    23. Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System. Skinmed · 2020
    24. Supplementary Figure 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer 2024
    25. Is polycystic ovary syndrome a risk factor for depression and anxiety?: a cross-sectional study Revista da Associação Médica Brasileira · 2024 · 3 citations
    26. Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants Annals of General Psychiatry · 2023 · 11 citations
    27. Finasteride use and suicide attempts through self-poisoning: A case–control study Clinical and Experimental Dermatology · 2025
    28. The Incidence of Alopecia Areata in a COVID-19-Vaccinated Population: A Single-Center Review Curēus · 2023
    29. Cardiovascular risk in patients with alopecia areata (AA): A propensity-matched retrospective analysis Journal of the American Academy of Dermatology · 2016 · 29 citations
    30. Sun-protection behaviors of melanoma survivors Journal of The American Academy of Dermatology · 2011 · 24 citations